Advanced molecular research techniques have transformed hematology in recent years. With improved understanding of hematologic diseases, we now have the opportunity to research and evaluate new biological therapies, new drugs and drug combinations, new treatment schedules and novel approaches including stem cell transplantation. We can also expect proteomics, molecular genetics and biomarker research to facilitate new diagnostic approaches and the identification of appropriate therapies. Further advances in our knowledge regarding the formation and function of blood cells and blood-forming tissues should ensue, and it will be a major challenge for hematologists to adopt these new paradigms and develop integrated strategies to define the best possible patient care. Expert Review of Hematology (1747-4086) puts these advances in context and explores how they will translate directly into clinical practice.
Expert Review of Medical Devices (ISSN 1743-4440) provides commentary, analysis and debate for all professionals involved in research, development, testing and clinical use of devices.The journal serves the device research community by providing a comprehensive body of high-quality information from leading experts, all subject to rigorous peer-review. The Expert Review format is specially structured to optimize the value of the information to reader. Comprehensive coverage by each author in a key area of research or clinical practice is augmented by the following sections:* Expert Commentary - the author's personal assessment of the most promising therapies or strategies* Five-year view - the author is challenged to predict how the particular field will evolve in the medium term* Key issues - an executive summary of the author's most important points and conclusionsIn addition to the Review program, each issue also features Medical Device Profiles - objective assessments of specific devices in development or clinical use to help inform clinical practice. There are also Perspectives - overviews highlighting areas of current debate and controversy, together with reports from the conference scene and invited Editorials.
Expert Review of Molecular Diagnostics publishes expert reviews of the latest advancements in the field of molecular diagnostics including the detection and monitoring of the molecular causes of disease that are being translated into groundbreaking diagnostic technologies to be used in the clinical diagnostic setting. Each issue of Expert Review of Molecular Diagnostics contains leading reviews on current and emerging topics relating to molecular diagnostics, subject to a rigorous peer review process; cutting-edge editorials discussing contentious issues in the field; diagnostic profiles featuring independent, expert evaluations of diagnostic tests; meeting reports of recent molecular diagnostics conferences and key paper evaluations reviewing significant, recently published articles carefully selected and assessed by specialists in molecular diagnostic therapy.
Expert Review of Neurotherapeutics (ISSN 1473-7175) provides expert reviews on the use of drugs and medicines in clinical neurology and neuropsychiatry. Coverage includes disease management, new medicines and drugs in neurology, therapeutic indications, diagnostics, medical treatment guidelines and neurological diseases such as stroke, epilepsy, Alzheimer's and Parkinson's.Comprehensive coverage in each review is complemented by the unique Expert Review format and includes the following sections:
Expert Review of Precision Medicine and Drug Development publishes original research and review articles covering the development and clinical application of medicine to be used in a personalized therapy setting. In an era where medicine is recognizing that a one-size-fits-all approach is not always appropriate, it has become necessary to identify patients responsive to treatments and treat patient populations using a tailored approach. Areas covered include:
Expert Review of Proteomics (ISSN 1478-9450) seeks to collect together technologies, methods and discoveries from the field of proteomics to advance scientific understanding of the many varied roles protein expression plays in human health and disease.The journal adopts the unique Expert Review article format, offering a complete overview of current thinking in a key technology area, research or clinical practice, augmented by the following sections:Expert commentary - a personal commentary on the most effective or promising strategiesFive-year view - a clear perspective of future prospects within a realistic timescaleKey issues - an executive summary cutting to the author's most critical points.
Expert Review of Vaccines (ISSN 1476-0584) provides expert reviews on the clinical effectiveness of new vaccines. Coverage includes vaccine technology, vaccine adjuvants, prophylactic vaccines, therapeutic vaccines, AIDS vaccines and vaccines in bioterrorism. All articles are subject to rigorous peer-review.
The editor invites original papers and short communications on the theory, fabrication, properties, and applications of ferroelectrics and related materials. In addition to research papers, Ferroelectrics publishes appropriate and timely review articles. Publication office: Taylor & Francis, Inc., 325 Chestnut Street, Suite 800, Philadelphia, PA 19106.
Ferroelectrics Letters permits the rapid publication of important, quality, short original papers on the theory, synthesis, properties and applications of ferroelectrics and related materials.
Fetal and Pediatric Pathology is an established bimonthly international journal that publishes data on diseases of the developing embryo, newborns, children, and adolescents. The journal publishes original and review articles and reportable case reports.The expanded scope of the journal encompasses molecular basis of genetic disorders; molecular basis of diseases that lead to implantation failures; molecular basis of abnormal placentation; placentology and molecular basis of habitual abortion; intrauterine development and molecular basis of embryonic death; pathogenisis and etiologic factors involved in sudden infant death syndrome; the underlying molecular basis, and pathogenesis of diseases that lead to morbidity and mortality in newborns; prenatal, perinatal, and pediatric diseases and molecular basis of diseases of childhood including solid tumors and tumors of the hematopoietic system; and experimental and molecular pathology.Read More: http://informahealthcare.com/page/pdp/Description.
Publication office: Taylor & Francis, Inc., 325 Chestnut Street, Suite 800, Philadelphia, PA 19106.
Fly is the first international peer-reviewed journal to focus exclusively on Drosophila research.Fly publishes broadly three general types of papers: original research, methods and technical advances and reviews and meeting reports.Topics in Drosophila research include: cell biology, development, gene regulation, chromosome dynamics, behavior, evolution, population biology, neurobiology, molecular biology and biochemistry, genomics and anything else that we might have left out or might come along.We will distinguish Fly from other journals in two important ways:First, we plan to have regular features of specific interest to the Drosophila community. For example: What's new on Flybase? How do I get my hands on all of those new stocks for doing that new cool technique? Who are the new researchers in the Drosophila field and what are they doing? What really great Drosophila papers were published recently? What's happening in those fields of Drosophila research outside my own? Is it possible to get a grant to do Drosophila research these days?Second, we want the journal to be highly interactive. We plan to develop a lively Letters to the Editor section, where issues of interest to the Drosophila community can be discussed, and where researchers can ask questions (and get answers!) about new resources and about how to obtain materials, comment on recent papers, make suggestions for new features in Fly.